Business Wire

Nitro Circus Live’s Travis Pastrana, Josh Sheehan and Gregg Duffy Make Action Sports History With Huge FMX World Firsts

Del

Nitro Circus Live tore up the history books Saturday, May 14 in Brisbane, Australia with a spectacular show that took freestyle motocross (FMX) to the next level. The legendary Travis Pastrana, champion rider Josh Sheehan and motocross racer Gregg Duffy all landed massive world firsts that redefined what is possible in the discipline. Click here for footage of these barrier-breaking feats.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160516005807/en/

The great Travis Pastrana led from the front on this historic night. He was first to hit the new, double sized takeoff ramp and attempted the world’s first Superman double backflip.

On his first attempt, Pastrana got the trick around on two wheels, but failed to ride out. Despite getting battered and bruised by that attempt, he went straight backstage and, without a moment’s hesitation, hurled himself back at the steepest freestyle ramp ever built and sent the crowd into a complete fever by perfectly landing and riding out of the world’s biggest new freestyle trick, a double backflip Superman.

Pastrana’s heroics were enough to convince Josh Sheehan, already the first rider on the planet to land a motorcycle triple backflip and the only man in the world currently performing the double backflip, to take the double to an entirely new, previously unthinkable level: adding a heel click while in the middle of the first of his two rotations. The packed house leaped to their feet and went absolutely ballistic after Sheehan came back down to earth.

Gregg Duffy’s landmark double frontflip is quite simply the biggest trick in FMX. It also is arguably the most dangerous, as fellow Nitro Circus teammate Bruce Cook knows first-hand. (Cook crashed on his 2014 attempt, fracturing his vertebrae, and became a paraplegic). Duffy, a longtime friend of Travis, trained for weeks at his Maryland, USA Pastranaland complex preparing for an opportunity to make history. When the moment came, Duffy stepped up in epic fashion, stomping the double front with almost perfect execution and riding away. Duffy was then absolutely mobbed by his fellow athletes and, in an incredibly touching moment, Duffy rode over to Bruce Cook where the two shared an extremely emotional and tearful embrace.

Afterwards Pastrana, the world’s greatest extreme sports athlete, said unequivocally, “I haven’t felt that type of energy in a crowd since X Games 2006 [when Travis landed world’s first double and won the gold, shocking the world]. That was without a doubt, one of the biggest nights in action sports history.”

Tour veterans consider Saturday night, Nitro Circus Live’s 205th performance, the greatest show in the global phenomenon’s 6-year history. Nitro Circus CEO and Creative Director Mike Porra went even further, saying, “We’ve just seen the biggest night in the last decade of action sports, if not ever. This has been three years in the making for Travis and it shows the guys’ unwavering courage and commitment to progression.”

Even though 2016 is just now approaching the halfway point, it is already Nitro Circus Live’s biggest year yet. For the first time ever, the Nitro crew is touring multiple territories simultaneously. A month into an extensive North American trek, with over 40 dates in first-time markets across the United States and Canada, Nitro Circus Live also recently kicked off its 10th Anniversary tour in Australia, celebrating the Aussie release of the hit DVD series that started it all. Tours of UK, Ireland and France will follow in June and July.

For Nitro Circus Live tickets, tour updates, exclusive behind-the-scenes content and more, go to nitrocircus.live. Follow Nitro Circus on Twitter: @nitrocircus and Facebook: www.facebook.com/NitroCircus.

About Nitro Circus

Named #22 on Forbes magazine’s 2015 list of America’s Most Promising Companies, Nitro Circus continues to position itself as the world’s leading youth action sports & entertainment brand. From humble beginnings in 2003 – with Jeremy Rawle, Gregg Godfrey and extreme sports superstar Travis Pastrana producing DVDs from a Utah garage -- to a smash TV series which has aired in over 60 countries, Nitro Circus has exploded to global popularity. In 2012, Nitro Circus: The Movie, featuring cast members from the hit television series, was released in cinemas worldwide. In 2015, Nitro Circus announced a partnership with NBC Sports Ventures. The multi-year strategic alliance will feature TV specials and series programming airing nationally in the U.S. on NBC and NBCSN as well as streamed on NBC Sports Live Extra.

The TV show was transformed by current CEO and action sports industry guru Michael Porra into a must-see live event in 2010, creating the global touring phenomenon that is Nitro Circus Live. Since its inaugural Australian trek six years ago, the show has travelled the globe, obliterating box office records and cultivating a legion of diehard fans. Nitro Circus has now rolled across five continents, blown away over two million fans and sold-out shows in the United States, Canada, Europe, Australia, New Zealand, China, Japan, the Middle East and South Africa. After close to 100 shows globally in 2015 and with a packed 2016 touring schedule on the books, Nitro Circus is the world’s most successful action sports touring brand.

Contact information

For Nitro Circus
Greg Terlizzi
greg@nitrocircus.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00Pressemelding

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i